Get the Stockscreener App
0.3857
4.40%
-0.0178
Incannex Healthcare Inc stock is traded at $0.3857, with a volume of 22.48M.
It is down -4.40% in the last 24 hours and down -16.92% over the past month.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.
See More
Previous Close:
$0.4035
Open:
$0.3731
24h Volume:
22.48M
Relative Volume:
0.31
Market Cap:
$70.49M
Revenue:
-
Net Income/Loss:
$-21.91M
P/E Ratio:
-0.2589
EPS:
-1.49
Net Cash Flow:
-
1W Performance:
+10.40%
1M Performance:
-16.92%
6M Performance:
+160.99%
1Y Performance:
-83.01%
1-Day Range:
$0.3643
$0.3863
1-Week Range:
$0.3382
$0.4142
52-Week Range:
$0.08
$3.1199
Incannex Healthcare Inc Stock (IXHL) Company Profile
Name
Incannex Healthcare Inc
Sector
Phone
61 409 840 786
Address
8 CENTURY CIRCUIT, NORWEST NSW
Compare IXHL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IXHL
Incannex Healthcare Inc
|
0.3857 | 140.30M | 0 | -21.91M | 0 | -1.49 |
|
ZTS
Zoetis Inc
|
143.87 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.37 | 41.80B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.24 | 40.88B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.14 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
444.10 | 19.53B | 3.08B | 1.24B | 1.07B | 25.61 |
Incannex Healthcare Inc Stock (IXHL) Latest News
Why Incannex Healthcare Inc. stock could see breakout soonRate Hike & Long-Term Safe Investment Ideas - newser.com
Can Incannex Healthcare Inc. recover in the next quarterMarket Performance Report & Community Shared Stock Ideas - newser.com
What does recent volatility data suggest for Incannex Healthcare Inc.July 2025 Snapshot & Stock Portfolio Risk Control - newser.com
Is Incannex Healthcare Inc. stock near bottom after declineOptions Play & Scalable Portfolio Growth Ideas - newser.com
Incannex Healthcare Highlights Clinical Progress in Shareholder Update - TipRanks
Incannex Healthcare Inc Provides Shareholder Update on Clinical Progress and Strategic Focus - TradingView
Incannex Provides Shareholder Update Highlighting Clinical Progress, Capital Discipline, and EOY 2025 Strategic Focus - The Manila Times
Incannex (Nasdaq: IXHL) posts PSX-001 Phase 2 GAD results with 11-week relief, no SAEs - Stock Titan
Is Incannex Healthcare Inc. stock bottoming out2025 Key Highlights & Reliable Price Breakout Signals - newser.com
Will Incannex Healthcare Inc. stock sustain high P E ratiosJuly 2025 Trends & AI Powered Buy and Sell Recommendations - newser.com
What to do if you’re stuck in Incannex Healthcare Inc.July 2025 PreEarnings & Fast Entry High Yield Tips - newser.com
How Incannex Healthcare Inc. (IQI0) stock reacts to Fed tighteningTake Profit & Weekly Breakout Watchlists - newser.com
Is Incannex Healthcare Inc IQI0 a good long term investmentFundamental Stock Analysis & Market Analysis Tools You Can Trust - earlytimes.in
Trend Recap: Why Incannex Healthcare Inc. stock could see breakout soon2025 Top Gainers & Precise Buy Zone Identification - Fundação Cultural do Pará
Is Incannex Healthcare Inc. stock ready for a breakoutJuly 2025 Final Week & Fast Gain Stock Tips - newser.com
Will Incannex Healthcare Inc. (IQI0) stock deliver stable dividendsPortfolio Risk Summary & High Yield Equity Trading Tips - newser.com
Incannex Healthcare (NASDAQ:IXHL) Receives Sell (E+) Rating from Weiss Ratings - MarketBeat
Incannex Healthcare Inc Stock (IXHL) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.68%
1.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):